Clomipramine Hydrochloride is a tricyclic antidepressant and the most serotonergically selective TCA, making it the pharmacological benchmark and first-line drug treatment for obsessive-compulsive disorder alongside its use in depression and panic disorder. Simson Pharma's Clomipramine Hydrochloride reference standard and impurities support stability-indicating testing for this long-established psychotropic.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Clomipramine Hydrochloride Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.